Streetbeat News

Products Services

BFRI

Biofrontera has announced the FDA's acceptance of a supplemental new drug application for Ameluz, allowing up to three tubes per use. The FDA has set a target action date of October 4, 2024.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 10:19 pm

GOOGL

META

Jeremy Schwartz, CIO at WisdomTree Investments, discussed Meta Platforms, Inc's (META) successful 'year of efficiency,' attributing the success to AI. Meta reduced its workforce by 22% while increasing revenue by 25% and its stock surged over 175% in 2023. Schwartz is bullish on AI's impact on the economy and suggests that other big tech companies like Alphabet, Inc. (GOOGL) might follow Meta's example by leveraging AI for efficiency and potentially introducing dividends.

Portfolio Pulse from Erica Kollmann

February 05, 2024 | 10:08 pm

BA

SPR

Spirit AeroSystems notified Boeing of a non-conformity found by an employee, which, after engineering review, was determined not to be a safety-of-flight issue. The review is ongoing, with a final disposition expected soon. Spirit will continue delivering fuselages with additional inspections and repairs as needed, maintaining normal production operations.

Portfolio Pulse from Charles Gross

February 05, 2024 | 10:06 pm

SPCE

Virgin Galactic Holdings, Inc. (SPCE) reported to the FAA that an alignment pin detached from the mothership during the 'Galactic 06' flight. The issue, discovered during a standard post-flight review, did not pose a safety risk to the crew or vehicles. Virgin Galactic is conducting a review with the FAA, emphasizing that the flight was successful and adhered to safety protocols.

Portfolio Pulse from Charles Gross

February 05, 2024 | 10:04 pm

LAKE

Lakeland Industries, Inc. (NASDAQ:LAKE) has acquired Jolly Scarpe S.p.A. and Jolly Scarpe Romania S.R.L. for approximately $9.3 million in an all-cash transaction. This acquisition expands Lakeland's global fire services portfolio by adding Jolly's leading professional footwear for first responders. Jolly, with 150 employees and operations in Italy and Romania, is expected to contribute $14 to $16 million in sales revenue to Lakeland this fiscal year and be immediately accretive. The acquisition enhances Lakeland's product offerings and geographic presence, presenting cross-selling opportunities across Lakeland's global sales and distribution channels.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 9:23 pm

LUNR

Intuitive Machines has successfully completed key milestones in the development of its lunar lander, which is now preparing for launch. This progress marks a significant step forward in the company's lunar exploration efforts.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 9:22 pm

PROP

Prairie Operating has expanded its DJ Basin portfolio by acquiring a 1,280 acre drillable spacing unit (DSU) and eight permitted PUDs for $900,000. This acquisition, along with the expected acquisition of 62 PUDs from Nickel Road Operating LLC, will increase Prairie's drilling inventory to 70 wells. The acquisition adds over 2.6 MMboe in reserves and approximately $40 million in PV10 value, with the PUDs being liquids rich and near existing midstream infrastructure.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 9:20 pm

XCUR

Exicure's stock price increased following the announcement of a patent license agreement with Bluejay Therapeutics for the development of cavrotolimod, aimed at treating hepatitis.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 9:16 pm

RGTI

Rigetti Computing, Inc. (NASDAQ:RGTI) has been awarded a grant by Innovate UK, funded by the National Quantum Computing Centre (NQCC), to develop and deliver a 24-qubit quantum computer based on its Ankaa-class architecture to the NQCC's Harwell Campus. The system will feature advanced technology from Rigetti's 84-qubit Ankaa-2 system, including tunable couplers and a square lattice, achieving a 98% median 2-qubit fidelity and a 68 nanoseconds gate time. Rigetti's software development tools and Tsunamis control systems will be deployed with the system, which will be available over Rigetti Quantum Cloud Services. Riverlane will integrate its Quantum Error Correction Stack, including Deltaflow.Control, to enhance the system's control and readout capabilities.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 9:15 pm

VRTX

Vertex Pharmaceuticals is on schedule to submit New Drug Applications (NDAs) to the FDA by mid-2024 for VX-548, aimed at treating acute pain, and the Vanzacaftor triple combination for Cystic Fibrosis (CF).

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 9:09 pm